Chardan Capital analysts are weighing in today on satellite company Globalstar, Inc. (NYSEMKT:GSAT) and drug maker Lion Biotechnologies Inc (NASDAQ:LBIO), as both stocks turned extremely volatile on the …
In a research report issued today, Roth Capital analyst Joseph Pantginis maintained a Buy rating on Lion Biotechnologies (OTC:LBIO) with a price target …
In a research report released this morning, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Lion Biotechnologies Inc. (LBIO) with a $20 …
